919
4-[4-({[3-tert-butyl-1-(quinolin-6-yl)-1H-pyrazol-5-yl]carbamoyl}amino)-3-fluorophenoxy]-N-methylpyridine-2-carboxamide
Find entries where: 919
is present as a standalone ligand in 6 entries
Chemical Component Summary | |
---|---|
Name | 4-[4-({[3-tert-butyl-1-(quinolin-6-yl)-1H-pyrazol-5-yl]carbamoyl}amino)-3-fluorophenoxy]-N-methylpyridine-2-carboxamide |
Synonyms | DCC-2036 |
Identifiers | 4-[4-[(5-tert-butyl-2-quinolin-6-yl-pyrazol-3-yl)carbamoylamino]-3-fluoro-phenoxy]-N-methyl-pyridine-2-carboxamide |
Formula | C30 H28 F N7 O3 |
Molecular Weight | 553.587 |
Type | NON-POLYMER |
Isomeric SMILES | CC(C)(C)c1cc(n(n1)c2ccc3c(c2)cccn3)NC(=O)Nc4ccc(cc4F)Oc5ccnc(c5)C(=O)NC |
InChI | InChI=1S/C30H28FN7O3/c1-30(2,3)26-17-27(38(37-26)19-7-9-23-18(14-19)6-5-12-33-23)36-29(40)35-24-10-8-20(15-22(24)31)41-21-11-13-34-25(16-21)28(39)32-4/h5-17H,1-4H3,(H,32,39)(H2,35,36,40) |
InChIKey | WVXNSAVVKYZVOE-UHFFFAOYSA-N |
Chemical Details | |
---|---|
Formal Charge | 0 |
Atom Count | 69 |
Chiral Atom Count | 0 |
Bond Count | 73 |
Aromatic Bond Count | 29 |
Drug Info: DrugBank
DrugBank ID | DB13005 |
---|---|
Name | Rebastinib |
Groups | investigational |
Description | Rebastinib has been used in trials studying the treatment of Chronic Myeloid Leukemia. It is an inhibitor of Tie2 tyrosine kinase receptor and an antineoplastic agent. |
Synonyms |
|
Categories |
|
CAS number | 1020172-07-9 |
Related Resource References
Resource Name | Reference |
---|---|
Pharos | CHEMBL1738757 |
PubChem | 25066467 |
ChEMBL | CHEMBL1738757 |
ChEBI | CHEBI:62166 |